ERDERA
Multinational research teams are invited to apply for ERDERA’s 2026 call focused on providing diagnostic clarity for unsolved rare genetic and nongenetic diseases. The call aims to close these gaps and deliver actionable diagnostic evidence for patients and families. Read more at this LINK.
Open Calls
Deadline for pre-proposal submission - 12 February 2026
Deadline for full proposal submission - 08 July 2026
EP PerMed
The European Partnership for Personalised Medicine (EP PerMed) is a Horizon Europe-funded initiative (launched in Nov 2023) that coordinates research, innovation, and implementation across Europe to accelerate personalised medicine. It brings together national/regional funding bodies, ministries, healthcare providers, industry, researchers, and patients to support the full “value continuum” — from basic research to clinical pilots and health system uptake.
Key goals include:
- Translating scientific discoveries into patient-centred applications
- Integrating big data, digital health, and omics technologies
- Strengthening health systems’ capacity to adopt personalised approaches
- Demonstrating the value (clinical, societal, economic) of personalised medicine for sustainable healthcare
To steer its work, EP PerMed follows a Strategic Research & Innovation Agenda (SRIA) that defines priorities and supports joint calls, pilot projects, capacity building, and policy dialogue.
Open Calls
Call Announcement - Research, Innovation and Technology Call for Proposals (RITC) 2026
Call Title: Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026). Call Text Link
EP PerMed will fund innovation projects in human health that focus on multimodal data usage for PM approaches aiming to provide more efficient and personalised management of patients with multimorbidity, having at least two chronic diseases that require management and adhere to the definition.
19 funding organizations participate in this call with an available budget of over 14.8 Mio. € (approx.). They have agreed to jointly fund multinational innovative research and technology projects in personalized medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.
The call will be implemented in two stages, i.e. a pre- and a full proposal phase.
Deadline for pre-proposal submission - 12 January 2026 (14:00, CET)
Deadline for full-proposal submission - 27 April 2026 (14:00, CEST)
IHI
The Innovative Health Initiative (IHI) is a European Partnership under Horizon Europe, funded jointly by the European Union via HE and by health industry partners.
The Innovative Health Initiative (IHI) is a large-scale public–private partnership that brings together the EU and health industry stakeholders to accelerate the development of innovative healthcare solutions. It funds collaborative, cross-sector projects that tackle complex challenges—spanning medicines, medical technologies, digital health, and patient care. By fostering collaboration between academia, industry, SMEs, and patient organisations, IHI aims to deliver more integrated, sustainable, and patient-centred innovations for Europe’s health systems.
Open Calls:
The call contains five topics, each focusing on one of the five IHI Specific Objectives (SOs) as set out in the Strategic Research and Innovation Agenda (SRIA):
- Topic 1 (SO1): Boosting innovation for a better understanding of the determinants of health
- Topic 2 (SO2): Boosting innovation through better integration of fragmented health R&I efforts
- Topic 3 (SO3): Boosting innovation for people-centred integrated healthcare solutions
- Topic 4 (SO4): Boosting innovation through exploitation of digitalisation and data exchange in healthcare
- Topic 5 (SO5): Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions
For full details of the topics, including the budget breakdown, read the call text. All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page. We advise you to read these documents, in particular the guide for applicants, carefully.
Mission Cancer
Horizon Europe Missions are a new programming approach under Pillar II – Global Challenges and European Industrial Competitiveness, designed with a horizontal, inter-cluster structure. They tackle major social and environmental challenges through bold, measurable objectives to be achieved within clear timelines. By mobilizing researchers, businesses, policymakers, and citizens, the Missions aim to accelerate innovation and deliver tangible benefits in areas such as climate adaptation, cancer, oceans, soil health, and climate-neutral cities.
Mission Cancer
The goal of the Mission on Cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better.
The four Cancer Mission objectives are:
✔ Understand;
✔ Prevent what is preventable;
✔ Optimise diagnosis and treatment;
✔ Support quality of life.
Its five transversal priorities are: ensure equitable access in all aforementioned areas, innovation, childhood cancer, personalised medicine and citizen engagement.
Open Calls
EU4Health
The EU4Health Programme is the EU’s dedicated health funding instrument for 2021–2027, created to strengthen Europe’s resilience to health crises and improve public health across member states. It supports actions that enhance disease prevention, reinforce health systems, improve access to medicines and medical devices, and boost cooperation at EU level. Through targeted funding, EU4Health aims to build a healthier, more prepared, and more equitable Europe.
The EU4Health Programme is managed by DG SANTE (Europen Commission).
Open Calls
3 open calls for proposals, collectively aiming to advance innovative medical countermeasures against chemical, biological, radiological, and nuclear threats by supporting new medicinal products, next-generation reusable protective equipment, and improved detection and diagnostic technologies.
MSCA Doctoral Networks
The Marie Skłodowska-Curie Actions (MSCA) support excellent research training, skills development, and international mobility for researchers at all career stages. Trough its main calls—Doctoral Networks, Postdoctoral Fellowships, Staff Exchanges, COFUND, and MSCA and Citizens—the programme strengthens Europe’s research landscape by fostering international collaboration, interdisciplinary learning, and the growth of highly skilled, globally connected researchers.
Doctoral Networks are a key component, funding international, interdisciplinary, and intersectoral doctoral programmes. They help institutions attract top talent, provide high-quality supervision, and equip PhD candidates with advanced scientific and transferable skills, preparing them for successful careers within and beyond academia.
Open Calls
Comin soon
ERC - European Research Council
The European Research Council (ERC) funds ground-breaking research driven by scientific excellence. Its highly competitive grants support individual researchers and their teams to pursue ambitious, curiosity-driven ideas with the potential to transform their fields. Open to all disciplines, the ERC empowers outstanding talent to push the frontiers of knowledge in Europe.
EIC - European Innovation Council
EIC Pathfinder is part of the European Innovation Council (EIC), designed to fund early-stage, high-risk / high-gain research that can pave the way to breakthrough technologies.
Within Pathfinder, the Open call is the “bottom-up” strand: it welcomes proposals in any field of science, technology or application, without predefined thematic priorities.
Open Calls
The 2026 Challenges Call includes three cutting-edge thematic strands that seek to push the frontiers of science and enable transformative technology development:
- II.2.1 Advanced Materials for Miniaturised Energy Harvesting Systems — This topic invites proposals to develop novel materials and device architectures that can efficiently scavenge ambient energy at microscale. The ambition is to enable self-powered miniaturised systems (e.g. IoT devices, sensors, wearable electronics) through breakthroughs in material properties, integration strategies, and energy conversion techniques.
- II.2.2 Biotechnology for Healthy Ageing — This theme focuses on leveraging biotechnology, bioengineering and life-science innovations to promote longer, healthier lifespans. It aims to address biological aging processes, preventative diagnostics, regenerative therapies, and interventions that maintain functional resilience over time.
- II.2.3 DeepRAP: Deep Reasoning, Abstraction & Planning towards Trustworthy Cognitive AI Systems — Under this call, the goal is to advance the methodological foundations of AI by combining deep learning with symbolic reasoning, abstraction, planning and verification. The ambition is to build more trustworthy, interpretable, and robust cognitive systems that can operate reliably in complex, uncertain environments.
EIC Pathfinder targets work in the earliest Technology Readiness Levels (TRLs), typically TRL 1 to TRL 4 — i.e. from basic research up to proof-of-concept / lab validation.
| Topic | Budget (EUR million) |
Budget/ project |
Number of projects expected to be funded | Deadline |
| Pathfinder OPEN | 166 | 4 | 41 |
06 May 2026
|
| Pathfinder CHALLENGES | 96 | 4 | 24 | 28 October 2026 |